Výsledky vyhledávání - "John E. Nugent"

Results of a Phase II Trial of Cetuximab plus Capecitabine/Irinotecan as First-Line Therapy for Patients with Advanced and/or Metastatic Colorectal Cancer

Autor: John E. Nugent, Robert L. Ruxer, Paul R. Kuefler, Kristi A. Boehm, Svetislava J. Vukelja, Donald A. Richards, Allen Lee Cohn, William J. Hyman, Maury Berger, Lina Asmar, Thomas H. Cartwright

Publikováno v: Clinical Colorectal Cancer. 7:390-397

XELIRI (capecitabine/irinotecan) is effective and well tolerated in metastatic colorectal cancer (mCRC). Cetuximab is active in mCRC alone or with chemotherapy. This study evaluated cetuximab plus XELIRI in first-line treatment of mCRC.Subjects had h

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::05bb26d37446f281e2952b5f9aff8815
https://doi.org/10.3816/ccc.2008.n.052

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání